Frontlight ResearchEarly access
Trial site
Utrecht
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers3 trials
- Chronic myeloid leukaemia2 trials
- Colorectal cancer2 trials
- Coronary artery disease2 trials
- Lung cancer2 trials
- Pancreatic cancer2 trials
- Stroke2 trials
- Triple-negative breast cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Gastric and oesophageal cancer1 trial
- Melanoma1 trial
- Spinal muscular atrophy1 trial
- Phase
- Phase 34 trials
- Phase 12 trials
- Phase 1/22 trials
- Phase 21 trial
- Status
- Recruiting4 trials
- Completed3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals9 trials
Running trials
Recruiting
Active, not recruiting
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Recruiting
Recruiting
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Site data: ClinicalTrials.govUpdated 15 Nov 2026